These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23940288)

  • 1. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival.
    Chubak J; Boudreau DM; Wirtz HS; McKnight B; Weiss NS
    J Natl Cancer Inst; 2013 Oct; 105(19):1456-62. PubMed ID: 23940288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions of Bias in Clinical Research.
    Warden G
    Methods Mol Biol; 2021; 2249():35-52. PubMed ID: 33871837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where to look for the most frequent biases?
    Jager KJ; Tripepi G; Chesnaye NC; Dekker FW; Zoccali C; Stel VS
    Nephrology (Carlton); 2020 Jun; 25(6):435-441. PubMed ID: 32133725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research.
    Haneuse S
    Med Care; 2016 Apr; 54(4):e23-9. PubMed ID: 24309675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.
    Mansournia MA; Higgins JP; Sterne JA; Hernán MA
    Epidemiology; 2017 Jan; 28(1):54-59. PubMed ID: 27748683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-bias Sensitivity Analysis Using Bounds.
    Smith LH; Mathur MB; VanderWeele TJ
    Epidemiology; 2021 Sep; 32(5):625-634. PubMed ID: 34224471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias in Clinical Research.
    Stuckless S; Parfrey PS
    Methods Mol Biol; 2021; 2249():17-34. PubMed ID: 33871836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative bias analysis for study and grant planning.
    Fox MP; Lash TL
    Ann Epidemiol; 2020 Mar; 43():32-36. PubMed ID: 32113733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Negative Controls to Detect Selection Bias and Measurement Bias in Epidemiologic Studies.
    Arnold BF; Ercumen A; Benjamin-Chung J; Colford JM
    Epidemiology; 2016 Sep; 27(5):637-41. PubMed ID: 27182642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic studies: pitfalls in interpretation.
    Westhoff CL
    Dialogues Contracept; 1995; 4(5):5-6, 8. PubMed ID: 12288680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity.
    Kim SY; Park JE; Lee YJ; Seo HJ; Sheen SS; Hahn S; Jang BH; Son HJ
    J Clin Epidemiol; 2013 Apr; 66(4):408-14. PubMed ID: 23337781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting the term selection bias in medical research.
    Mark DH
    Fam Med; 1997 Feb; 29(2):132-6. PubMed ID: 9048175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification, direction, and prevention of bias in epidemiologic research.
    Choi BC; Noseworthy AL
    J Occup Med; 1992 Mar; 34(3):265-71. PubMed ID: 1545278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Confounding and Selection Bias in Epidemiological Studies of Populations Exposed to Low-Dose, High-Energy Photon Radiation.
    Schubauer-Berigan MK; Berrington de Gonzalez A; Cardis E; Laurier D; Lubin JH; Hauptmann M; Richardson DB
    J Natl Cancer Inst Monogr; 2020 Jul; 2020(56):133-153. PubMed ID: 32657349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating epidemiologic evidence of the effects of food and nutrient exposures.
    Flegal KM
    Am J Clin Nutr; 1999 Jun; 69(6):1339S-1344S. PubMed ID: 10359234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A counterfactual approach to bias and effect modification in terms of response types.
    Suzuki E; Mitsuhashi T; Tsuda T; Yamamoto E
    BMC Med Res Methodol; 2013 Jul; 13():101. PubMed ID: 23902658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
    Pottegård A; Friis S; Stürmer T; Hallas J; Bahmanyar S
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):451-459. PubMed ID: 29265740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative controls: a tool for detecting confounding and bias in observational studies.
    Lipsitch M; Tchetgen Tchetgen E; Cohen T
    Epidemiology; 2010 May; 21(3):383-8. PubMed ID: 20335814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.